Browsing by Author Xue, Aiqun

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2016Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In VivoBulanadi, Jerikho C; Gill, Anthony; Julovi, Sohel; Smith, Ross; Thanh LE, T N; Xue, Aiqun; Moghaddam, Minoo J; Patel, Mili; Rye, Kerry-Anne; Waddington, Lynne; Northern Clinical School: Kolling Institute; Northern Clinical School: Pathology; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: SurgeryApolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo, PloS One, vol.11, 3, 2016,pp 1-14
2007Classification of pancreatic cystic lesions using seldi-tof mass spectrometryBaxter, Robert; Samra, Jaswinder; Scarlett, C; Smith, Ross; Xue, Aiqun; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Medicine; Surgery; MedicineClassification of pancreatic cystic lesions using seldi-tof mass spectrometry, ANZ Journal of Surgery, vol.77,(8),2007,pp 648-653
2011A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary stricturesGill, Anthony; Sanadanayake, N; Smith, Ross; Xue, Aiqun; Andreola, F; Chapman, M; Clarkson, A; Norton, I D; Pereira, S; Sinclair, J; Timms, J; Webster, G; Northern Clinical School: Pathology; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: SurgeryA combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures, British Journal of Cancer, vol.105, 9, 2011,pp 1370-1378
2014Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinomaBaxter, Robert; Gill, Anthony; Hugh, Thomas; Julovi, Sohel; Pavlakis, Nick; Peters, Lyndsay; Smith, Ross; Wong, Matthew; Xue, Aiqun; Samra, Jas; Northern Clinical School: Kolling Institute; Northern Clinical School: Pathology; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Medicine; Northern Clinical School: SurgeryCotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma, Clinical Cancer Research, vol.20, 10, 2014,pp 4047-4058
2008Diagnostic and prognostic significance of uPAR and PAI-2 in pancreatic ductal adenocarcinoma using multigene assayAllen, Barry; Scarlett, C; Smith, Ross; Xue, Aiqun; Jackson, Christopher J; Physics; Northern Clinical School: Medicine; Surgery; MedicineDiagnostic and prognostic significance of uPAR and PAI-2 in pancreatic ductal adenocarcinoma using multigene assay, Pancreas, vol.36,(2),2008,pp 160-167
2012Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MSBaxter, Robert; Chung, Liping; Gandy, Robert; Smith, Ross; Xue, Aiqun; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Northern Clinical School: SurgeryDiscovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS, Pancreatology, vol.12, 2, 2012,pp 124-129
2010Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysisBaxter, Robert; Chung, Liping; Gandy, Robert Charles; Scarlett, C; Smith, Ross; Xue, Aiqun; Butturini, G.; Scarpa, A.; Wilson, S. R.; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: SurgeryDiscovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis, British Journal of Cancer, vol.103, 3, 2010,pp 391-400
2007High Expression of Plasminogen Activator Inhibitor-2 (PAI-2) is a Predictor of Improved Survival in Patients with Pancreatic AdenocarcinomaGill, Anthony; Hugh, Thomas; Saxby, Alex; Scarlett, C; Smith, Ross; Xue, Aiqun; Clarkson, Adele; Deans Unit: (CIPHER); Northern Clinical School: Surgery; Clinical Schools; Northern Clinical School: Medicine; Surgery; MedicineHigh Expression of Plasminogen Activator Inhibitor-2 (PAI-2) is a Predictor of Improved Survival in Patients with Pancreatic Adenocarcinoma, World Journal of Surgery, vol.31,(3),2007,pp 493-502
2007Parenteral versus enteral nutrition: effect on serum cytokines and the hepatic expression of mRNA of suppressor of cytokine signaling proteins, insulin-like growth factor-1 and the growth hormone receptor in rodent sepsisKee, Anthony; Scarlett, C; Sevette, A; Smith, Ross; Xue, Aiqun; O'Leary, Michael J.; Exercise & Sport Science; Northern Clinical School: Medicine; Clinical Schools; Surgery; MedicineParenteral versus enteral nutrition: effect on serum cytokines and the hepatic expression of mRNA of suppressor of cytokine signaling proteins, insulin-like growth factor-1 and the growth hormone receptor in rodent sepsis, Critical Care, vol.11,(4),2007,pp 1-8
2015A patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreasGill, Anthony; Hugh, Thomas; Julovi, Sohel; Samra, Jaswinder; Smith, Ross; Toon, Christopher Chien; Wong, Matthew; Xue, Aiqun; Northern Clinical School: Pathology; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Medicine; Northern Clinical School: SurgeryA patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreas, Pancreatology, vol.15, 4, 2015,pp 397-404
2012Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinomaBaxter, Robert; Chung, Liping; Gill, Anthony; Hugh, Thomas; Samra, Jaswinder; Smith, Ross; Xue, Aiqun; Butterini, Giovanni; Chang, J W; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Pathology; Northern Clinical School: Surgery; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Northern Clinical School: SurgerySerum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma, British Journal of Cancer, vol.107, 11, 2012,pp 1883-1891
2009Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signalingJackson, Christopher; Smith, Ross; Xue, Aiqun; Xue, Meilang; Northern Clinical School: Medicine; Northern Clinical School: Surgery; Northern Clinical School: Surgery; Northern Clinical School: MedicineSuppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling, The International Journal of Biochemistry & Cell Biology, vol.41, N/A,pp 1731-1738
2016Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal AdenocarcinomaBaxter, Robert; Pavlakis, Nick; Smith, Ross; Wong, Matthew; Xue, Aiqun; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Medicine; Northern Clinical School: SurgeryUpstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma, NeoPlasia: an international journal of oncology research, vol.18, 7, 2016,pp 425-435